153 related articles for article (PubMed ID: 25200921)
1. First and second trimester maternal serum markers in pregnancies with a vanishing twin.
Huang T; Boucher K; Aul R; Rashid S; Meschino WS
Prenat Diagn; 2015 Jan; 35(1):90-6. PubMed ID: 25200921
[TBL] [Abstract][Full Text] [Related]
2. First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P; Wright A; Syngelaki A; Konstantinidou L; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):326-331. PubMed ID: 31710734
[TBL] [Abstract][Full Text] [Related]
3. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
Svirsky R; Levinsohn-Tavor O; Feldman N; Klog E; Cuckle H; Maymon R
Ultrasound Obstet Gynecol; 2016 May; 47(5):560-4. PubMed ID: 25865365
[TBL] [Abstract][Full Text] [Related]
4. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers.
Spencer K; Staboulidou I; Nicolaides KH
Prenat Diagn; 2010 Mar; 30(3):235-40. PubMed ID: 20066674
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
6. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
7. Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies.
Garchet-Beaudron A; Dreux S; Leporrier N; Oury JF; Muller F; ;
Prenat Diagn; 2008 Dec; 28(12):1105-9. PubMed ID: 19003979
[TBL] [Abstract][Full Text] [Related]
8. Cross-trimester marker ratios in prenatal screening for Down syndrome.
Wald NJ; Bestwick JP; Morris JK
Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
[TBL] [Abstract][Full Text] [Related]
9. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Prenat Diagn; 2010 May; 30(5):413-7. PubMed ID: 20306463
[TBL] [Abstract][Full Text] [Related]
10. First trimester biochemical markers in twin pregnancies.
Celen S; Engin-Ustün Y; Türkçapar F; Aktulay A; Yilmaz N; Oksüzoğlu A; Yörük O; Danişman N
Ginekol Pol; 2015 May; 86(5):362-5. PubMed ID: 26117974
[TBL] [Abstract][Full Text] [Related]
11. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
[TBL] [Abstract][Full Text] [Related]
12. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
Prats P; Rodríguez I; Comas C; Puerto B
Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
[TBL] [Abstract][Full Text] [Related]
13. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening.
Lambert-Messerlian GM; Palomaki GE; Eklund EE; Kloza EM; Neveux LM; Phipps MG; Canick JA
J Med Screen; 2012 Dec; 19(4):164-70. PubMed ID: 23277614
[TBL] [Abstract][Full Text] [Related]
15. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Biochemical Analytes Used for Aneuploidy Screening and Adverse Pregnancy Outcomes in Twin Gestations.
Rosner JY; Fox NS; Saltzman D; Klauser CK; Rebarber A; Gupta S
Am J Perinatol; 2015 Dec; 32(14):1331-5. PubMed ID: 26375045
[TBL] [Abstract][Full Text] [Related]
17. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
[TBL] [Abstract][Full Text] [Related]
18. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K; Kagan KO; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
[TBL] [Abstract][Full Text] [Related]
19. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test.
Curnow KJ; Wilkins-Haug L; Ryan A; Kırkızlar E; Stosic M; Hall MP; Sigurjonsson S; Demko Z; Rabinowitz M; Gross SJ
Am J Obstet Gynecol; 2015 Jan; 212(1):79.e1-9. PubMed ID: 25447960
[TBL] [Abstract][Full Text] [Related]
20. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
